NSE - Delayed Quote INR
Venus Remedies Limited (VENUSREM.NS)
318.65
-16.00
(-4.78%)
At close: April 25 at 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
372,853
366,274
411,018
1,318,369
Investing Cash Flow
--
-72,093
-508,296
-167,269
564,938
Financing Cash Flow
--
-10,827
-5,675
-94,771
-1,622,426
End Cash Position
--
489,558
212,122
432,556
288,792
Capital Expenditure
--
-135,178
-78,180
--
--
Issuance of Capital Stock
--
--
--
--
137,521
Repayment of Debt
--
-9,891
-4,495
-90,156
-1,689,746
Free Cash Flow
--
237,675
288,094
411,018
1,318,369
3/31/2021 - 12/20/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GUJTHEM.NS Gujarat Themis Biosyn Limited
283.20
-4.52%
LACTOSE.BO Lactose (India) Limited
123.85
+1.99%
AKUMS.NS AKUMS DRUGS AND PHARMA L
530.60
+0.12%
JBCHEPHARM.NS J. B. Chemicals & Pharmaceuticals Limited
1,573.70
-2.20%
GLAND.NS Gland Pharma Limited
1,447.90
-1.20%
SPARC.NS Sun Pharma Advanced Research Company Limited
149.77
-3.37%
ZYDUSLIFE.NS Zydus Lifesciences Limited
859.65
-2.34%